Basics IDEAYA Biosciences, Inc. IPO Date: May 20, 2019 Sector: Healthcare Industry: Biotech Market Cap: $3.14B Activated in VL: True Average Daily Range Avg Daily Range: $0.51 | 2.91% Avg Daily Range (30 D): $0.65 | 2.03% Avg Daily Range (90 D): $0.58 | 2.05% Institutional Daily Volume Avg Daily Volume: .42M Avg Daily Volume (30 D): .79M Avg Daily Volume (90 D): .95M Trade Size Avg Trade Size (Sh.): 68 Avg Trade Size (Sh.) (30 D): 57 Avg Trade Size (Sh.) (90 D): 63 Institutional Trades Total Inst.Trades: 2,563 Avg Inst. Trade: $2.39M Avg Inst. Trade (30 D): $3.03M Avg Inst. Trade (90 D): $2.4M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.14M Avg Closing Trade (30 D): $4.46M Avg Closing Trade (90 D): $4.27M Avg Closing Volume: 120.18K     News Oct 14, 2025 @ 5:00 PM Melanoma Clinical Trial Pipeline Accelerates as 15... Source: Delveinsight Aug 5, 2025 @ 8:23 PM IDEAYA (IDYA) Q2 Net Loss Improves 27% Source: Jesterai Jul 22, 2025 @ 5:00 PM Melanoma Market Anticipates a Dynamic Shift During... Source: Delveinsight Jul 10, 2024 @ 12:01 PM Kura Sushi Posts Weak Q3 Results, Joins LegalZoom.... Source: Avi Kapoor Jul 9, 2024 @ 12:31 PM Company News for July 9, 2024 - July 9, 2024 - Zac... Source: N/A Financials   TTM Q3 2025 Q2 2025 Basic EPS $-1.89 $1.35 $-.88 Diluted EPS $-1.89 $1.33 $-.88 Revenue $ 214.83M $ 207.83M $ M Gross Profit $ $ $ Net Income / Loss $ -160.74M $ 119.24M $ -77.49M Operating Income / Loss $ -208.88M $ 108.45M $ -88.81M Cost of Revenue $ $ $ Net Cash Flow $ -101.46M $ 184.28M $ -15.35M PE Ratio